30 M Pill - purple round, 7mm
Pill with imprint 30 M is Purple, Round and has been identified as Morphine Sulfate Extended-Release 30 mg. It is supplied by Mallinckrodt Pharmaceuticals.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for 30 M
Morphine Sulfate Extended-Release
- Imprint
- 30 M
- Strength
- 30 mg
- Color
- Purple
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mallinckrodt Pharmaceuticals
- Inactive Ingredients
-
hypromellose 2208 (15000 mPa.s),
lactose monohydrate,
magnesium stearate,
polydextrose,
silicon dioxide,
titanium dioxide,
triacetin,
FD&C Blue No. 2,
D&C Red No. 7 Calcium Lake
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00406-8330 | Mallinckrodt Inc. |
| 66267-1269 | Nucare Pharmaceuticals Inc. (repackager) |
| 68071-0285 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "30 M"
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
Other brands
MS Contin, Roxanol, Duramorph, Kadian, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Duramorph, Kadian, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.